About: Mammoth Biosciences

An Entity of Type: Thing, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Mammoth Biosciences is a biotechnology company based in South San Francisco, California developing diagnostic tests using CRISPR-Cas12a. The company was founded in 2017 by Jennifer Doudna, Janice Chen, Trevor Martin, and Lucas Harrington of the University of California, Berkeley. Mammoth signed agreements in December 2019 and January 2020 with Horizon Discovery to combine Mammoth's intellectual property in CRISPR with Horizon's expertise in Chinese hamster ovary cells. Also in 2020, both Mammoth Biosciences and Sherlock Biosciences from the Broad Institute used their similar CRISPR technologies to develop tests for COVID-19. The technology, which is owned under the trademark of DETECTR BOOST, has been contracted to be manufactured by Merck & Co.

Property Value
dbo:abstract
  • Mammoth Biosciences is a biotechnology company based in South San Francisco, California developing diagnostic tests using CRISPR-Cas12a. The company was founded in 2017 by Jennifer Doudna, Janice Chen, Trevor Martin, and Lucas Harrington of the University of California, Berkeley. Mammoth signed agreements in December 2019 and January 2020 with Horizon Discovery to combine Mammoth's intellectual property in CRISPR with Horizon's expertise in Chinese hamster ovary cells. Also in 2020, both Mammoth Biosciences and Sherlock Biosciences from the Broad Institute used their similar CRISPR technologies to develop tests for COVID-19. The technology, which is owned under the trademark of DETECTR BOOST, has been contracted to be manufactured by Merck & Co. (en)
dbo:wikiPageID
  • 67781079 (xsd:integer)
dbo:wikiPageLength
  • 2539 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1079891835 (xsd:integer)
dbo:wikiPageWikiLink
dbp:wikiPageUsesTemplate
dcterms:subject
rdfs:comment
  • Mammoth Biosciences is a biotechnology company based in South San Francisco, California developing diagnostic tests using CRISPR-Cas12a. The company was founded in 2017 by Jennifer Doudna, Janice Chen, Trevor Martin, and Lucas Harrington of the University of California, Berkeley. Mammoth signed agreements in December 2019 and January 2020 with Horizon Discovery to combine Mammoth's intellectual property in CRISPR with Horizon's expertise in Chinese hamster ovary cells. Also in 2020, both Mammoth Biosciences and Sherlock Biosciences from the Broad Institute used their similar CRISPR technologies to develop tests for COVID-19. The technology, which is owned under the trademark of DETECTR BOOST, has been contracted to be manufactured by Merck & Co. (en)
rdfs:label
  • Mammoth Biosciences (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
is dbo:employer of
is dbo:wikiPageWikiLink of
is dbp:employer of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License